Back

Pilot study: The LIPL-PLATELET study postprandial LIPid paneLs and PLATELET activity in coronary heart disease after treatment with PCSK9-inhibitors

13 April 2023 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Moderated ePoster 10 Drug therapy EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Edita Pogran

Ottakring Clinic, Vienna (Austria)

8 More presentations in this session

Presentation thumbnail
The LIPL Study Postprandial lipid profile, inflammation and platelet activity in patients with chronic coronary syndrome
Doctor E. Pogran (Vienna, AT)
Abstract Slides
Presentation thumbnail
Predictors of cardiovascular disease in a familial hypercholesterolemia unit
Doctor G. Cortez Quiroga (Andújar, ES)
Abstract Slides
Presentation thumbnail
Discordance between LDL cholesterol and apolypoprotein B. Which to prefer to guide treatment?
Miss L. Cobarro Galvez (Madrid, ES)
Abstract Slides
Presentation thumbnail
Impact of lipid lowering therapies after an acute coronary syndrome, applied through telematic consultation, in a cohort of elderly patients
Mr D. Mialdea Salmeron (Cadiz, ES)
Abstract Slides
Presentation thumbnail
Evaluation of Triglycerides-glucose (TyG) index in a cardiac rehabilitation program. Looking for associations and outcomes.
Mr R. Martinez Gonzalez (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePoster 10

The Event

Event poster

ESC Preventive Cardiology 2023

13 April - 15 April 2023
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Fix the plaque, fight the lipids: why low-density lipoproteins still matter after percutaneous coronary intervention
thumbnail
Congress Presentation
What’s new in LDL lowering?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources